Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52,664,292
-
Total 13F shares
-
221,059
-
Share change
-
+110,087
-
Total reported value
-
$379,002
-
Price per share
-
$1.72
-
Number of holders
-
11
-
Value change
-
-$28,863
-
Number of buys
-
8
-
Number of sells
-
2
Institutional Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q4 2018
As of 31 Dec 2018,
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
221,059 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, DIMENSIONAL FUND ADVISORS LP, UBS Group AG, BlackRock Inc., CITIGROUP INC, BANK OF AMERICA CORP /DE/, and MORGAN STANLEY.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.